Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14112419
Abstract: Therapeutic blood products including convalescent plasma/serum and immunoglobulins concentrated from convalescent plasma, such as intravenous immunoglobulins or hyperimmune globulins, and monoclonal antibodies are passive immunotherapy options for novel coronavirus disease 2019 (COVID-19). They have been… read more here.
Keywords: therapeutic blood; blood products; viral inactivation; sars cov ... See more keywords